Filter posts

Senator Hatch Calls Out IPR Flaws

During today’s Senate Judiciary hearing, Senator Orrin Hatch addressed the dysfunctional interplay of the inter …

Governors Take Center Stage at State Bioscience Economic Development Panel

Governors and policymakers across the country understand value of bioscience jobs whether they be health …

Director of USPTO Addressed Intellectual Property Track Opening Plenary

This afternoon USPTO Director Andrei Iancu delivered remarks at the BIO International Convention’s Intellectual Property Track …

New Study Shows Strong Interest in China Partnerships

A new report suggests that biopharmaceutical companies are expressing strong interest in the Chinese marketplace. …

HHS Secretary Azar Calls for Strengthened Global Health Through Innovation

Last week Health and Human Services Secretary Alex Azar spoke in Geneva at the 71st …

Countdown to #BIO2018 – Two days to go!

This may be BIO’s 25th Anniversary, but there are plenty of firsts within the BIO …

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix...

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak …

Patents Are The Lifeblood of Biotechnology

Strong patents are the lifeblood of the biotechnology industry. They are critical in ensuring a …

Reps. Upton and Dingell on Solving America's Opioid Crisis

Writing this morning for the Detroit Free Press, Reps. Fred Upton (R-MI) and Debbie Dingell (D-MI) …

Important South Dakota Biologics Substitution Bill Heads to Governor's Desk

One of BIO’s top priorities is passage of state laws that establish consistent standards for …